Development of Targeted Alpha Particle Therapy for Solid Tumors

Targeted alpha-particle therapy (TAT) aims to selectively deliver radionuclides emitting α-particles (cytotoxic payload) to tumors by chelation to monoclonal antibodies, peptides or small molecules that recognize tumor-associated antigens or cell-surface receptors. Because of the high linear energy...

Descripción completa

Detalles Bibliográficos
Autores principales: Tafreshi, Narges K., Doligalski, Michael L., Tichacek, Christopher J., Pandya, Darpan N., Budzevich, Mikalai M., El-Haddad, Ghassan, Khushalani, Nikhil I., Moros, Eduardo G., McLaughlin, Mark L., Wadas, Thaddeus J., Morse, David L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930656/
https://www.ncbi.nlm.nih.gov/pubmed/31779154
http://dx.doi.org/10.3390/molecules24234314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930656/
https://www.ncbi.nlm.nih.gov/pubmed/31779154
http://dx.doi.org/10.3390/molecules24234314

Ejemplares similares